Philosopher Clancy Martin, PhD, shares his own experience with addiction and the role AA played in his recovery.

There’s been a big push in the past decade for screening, brief intervention, and referral to treatment (SBIRT), and evidence seems to support its effectiveness.

Considering the increased efforts to legalize marijuana in many states, greater public awareness of marijuana and its potential medicinal uses, and new research on cannabis and its constituents, it is essential that psychiatrists understand some of its proposed benefits—and fundamental risks.

President of the California Society of Addiction Medicine Itai Danovitch offers an overview of what psychiatrists should know about medical marijuana.

A recent study found that 18% of Ivy League students have used stimulants to improve academic performance, according to information scheduled to be presented at the annual meeting of the Pediatric Academic Societies in Vancouver, BC, in May.

The Transtheoretical Model (TTM) of behavior change has become almost universally accepted in addiction treatment. Like all dogmas, it is rarely critically examined, leading to blind belief and unskilled use.

Chronic care management (CCM), used successfully to treat other chronic diseases such as diabetes and cardiovascular disease, is one approach being looked at to improve care and clinical outcomes for patients with addiction.

Can electronic cigarettes, commonly referred to as e-cigarettes, play a role in helping people quit smoking tobacco?

Australian researchers recently reported data on the impact of a program called Resilient Families—an intervention aimed at preventing early use of alcohol, as well as frequent and heavy alcohol use, among adolescents in secondary schools in Melbourne.

Two of the biggest names in addiction treatment—Hazelden in Minnesota and the Betty Ford Clinic in California—plan to merge and will create the largest nonprofit addiction treatment provider in the country.